Editas Medicine Strengthens Board of Directors with Appointment of Patrick T. Ellinor, M.D., Ph.D.
Editas Medicine announced the appointment of Dr. Patrick T. Ellinor, a leading cardiovascular genetics researcher and executive, to its Board of Directors, replacing Dr. Elliott Levy. Dr. Ellinor's expertise in cardiovascular disease genetics and therapeutic innovation is expected to support Editas' development of gene editing medicines, particular…